Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

NCT01349959 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Male Breast Carcinoma
Recurrent Breast Carcinoma
Stage IIIC Breast Cancer AJCC v7
Stage IV Breast Cancer AJCC v6 and v7
Triple-Negative Breast Carcinoma

Interventions

DRUG: Azacitidine
DRUG: Entinostat
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

National Cancer Institute (NCI)